Bioresorbable vascular scaffold Korean expert panel report

Jung Min Ahn, Duk Woo Park, Sung Jin Hong, Young Keun Ahn, Joo Yong Hahn, Won Jang Kim, Soon Jun Hong, Chang Wook Nam, Do Yoon Kang, Seung Yul Lee, Woo Jung Chun, Jung Ho Heo, Deok Kyu Cho, Jin Won Kim, Sung Ho Her, Sang Wook Kim, Sang Yong Yoo, Myeong Ki Hong, Seung Jea Tahk, Kee Sik KimMoo Hyun Kim, Yangsoo Jang, Seung Jung Park

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.

Original languageEnglish
Pages (from-to)795-810
Number of pages16
JournalKorean Circulation Journal
Volume47
Issue number6
DOIs
Publication statusPublished - 2017 Nov

Fingerprint

Blood Vessels
Safety
Drug-Eluting Stents
Korea
Patient Selection
Registries
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Ahn, J. M., Park, D. W., Hong, S. J., Ahn, Y. K., Hahn, J. Y., Kim, W. J., ... Park, S. J. (2017). Bioresorbable vascular scaffold Korean expert panel report. Korean Circulation Journal, 47(6), 795-810. https://doi.org/10.4070/kcj.2017.0300
Ahn, Jung Min ; Park, Duk Woo ; Hong, Sung Jin ; Ahn, Young Keun ; Hahn, Joo Yong ; Kim, Won Jang ; Hong, Soon Jun ; Nam, Chang Wook ; Kang, Do Yoon ; Lee, Seung Yul ; Chun, Woo Jung ; Heo, Jung Ho ; Cho, Deok Kyu ; Kim, Jin Won ; Her, Sung Ho ; Kim, Sang Wook ; Yoo, Sang Yong ; Hong, Myeong Ki ; Tahk, Seung Jea ; Kim, Kee Sik ; Kim, Moo Hyun ; Jang, Yangsoo ; Park, Seung Jung. / Bioresorbable vascular scaffold Korean expert panel report. In: Korean Circulation Journal. 2017 ; Vol. 47, No. 6. pp. 795-810.
@article{533de7a9fd0d4d079902c41142455606,
title = "Bioresorbable vascular scaffold Korean expert panel report",
abstract = "Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.",
author = "Ahn, {Jung Min} and Park, {Duk Woo} and Hong, {Sung Jin} and Ahn, {Young Keun} and Hahn, {Joo Yong} and Kim, {Won Jang} and Hong, {Soon Jun} and Nam, {Chang Wook} and Kang, {Do Yoon} and Lee, {Seung Yul} and Chun, {Woo Jung} and Heo, {Jung Ho} and Cho, {Deok Kyu} and Kim, {Jin Won} and Her, {Sung Ho} and Kim, {Sang Wook} and Yoo, {Sang Yong} and Hong, {Myeong Ki} and Tahk, {Seung Jea} and Kim, {Kee Sik} and Kim, {Moo Hyun} and Yangsoo Jang and Park, {Seung Jung}",
year = "2017",
month = "11",
doi = "10.4070/kcj.2017.0300",
language = "English",
volume = "47",
pages = "795--810",
journal = "Korean Circulation Journal",
issn = "1738-5520",
publisher = "Korean Society of Circulation",
number = "6",

}

Ahn, JM, Park, DW, Hong, SJ, Ahn, YK, Hahn, JY, Kim, WJ, Hong, SJ, Nam, CW, Kang, DY, Lee, SY, Chun, WJ, Heo, JH, Cho, DK, Kim, JW, Her, SH, Kim, SW, Yoo, SY, Hong, MK, Tahk, SJ, Kim, KS, Kim, MH, Jang, Y & Park, SJ 2017, 'Bioresorbable vascular scaffold Korean expert panel report', Korean Circulation Journal, vol. 47, no. 6, pp. 795-810. https://doi.org/10.4070/kcj.2017.0300

Bioresorbable vascular scaffold Korean expert panel report. / Ahn, Jung Min; Park, Duk Woo; Hong, Sung Jin; Ahn, Young Keun; Hahn, Joo Yong; Kim, Won Jang; Hong, Soon Jun; Nam, Chang Wook; Kang, Do Yoon; Lee, Seung Yul; Chun, Woo Jung; Heo, Jung Ho; Cho, Deok Kyu; Kim, Jin Won; Her, Sung Ho; Kim, Sang Wook; Yoo, Sang Yong; Hong, Myeong Ki; Tahk, Seung Jea; Kim, Kee Sik; Kim, Moo Hyun; Jang, Yangsoo; Park, Seung Jung.

In: Korean Circulation Journal, Vol. 47, No. 6, 11.2017, p. 795-810.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bioresorbable vascular scaffold Korean expert panel report

AU - Ahn, Jung Min

AU - Park, Duk Woo

AU - Hong, Sung Jin

AU - Ahn, Young Keun

AU - Hahn, Joo Yong

AU - Kim, Won Jang

AU - Hong, Soon Jun

AU - Nam, Chang Wook

AU - Kang, Do Yoon

AU - Lee, Seung Yul

AU - Chun, Woo Jung

AU - Heo, Jung Ho

AU - Cho, Deok Kyu

AU - Kim, Jin Won

AU - Her, Sung Ho

AU - Kim, Sang Wook

AU - Yoo, Sang Yong

AU - Hong, Myeong Ki

AU - Tahk, Seung Jea

AU - Kim, Kee Sik

AU - Kim, Moo Hyun

AU - Jang, Yangsoo

AU - Park, Seung Jung

PY - 2017/11

Y1 - 2017/11

N2 - Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.

AB - Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.

UR - http://www.scopus.com/inward/record.url?scp=85039859717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039859717&partnerID=8YFLogxK

U2 - 10.4070/kcj.2017.0300

DO - 10.4070/kcj.2017.0300

M3 - Review article

AN - SCOPUS:85039859717

VL - 47

SP - 795

EP - 810

JO - Korean Circulation Journal

JF - Korean Circulation Journal

SN - 1738-5520

IS - 6

ER -

Ahn JM, Park DW, Hong SJ, Ahn YK, Hahn JY, Kim WJ et al. Bioresorbable vascular scaffold Korean expert panel report. Korean Circulation Journal. 2017 Nov;47(6):795-810. https://doi.org/10.4070/kcj.2017.0300